Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Treatment
48 results:

  • 1. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
    Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
    Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. 1,8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1α downregulation.
    Hwang SJ; Cho SH; Bang HJ; Hong JH; Kim KH; Lee HJ
    Biochem Pharmacol; 2024 Feb; 220():115972. PubMed ID: 38072164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
    Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of craf and MEK1/2.
    Wang P; Jia X; Lu B; Huang H; Liu J; Liu X; Wu Q; Hu Y; Li P; Wei H; Liu T; Zhao D; Zhang L; Tian X; Jiang Y; Qiao Y; Nie W; Ma X; Bai R; Peng C; Dong Z; Liu K
    Signal Transduct Target Ther; 2023 Mar; 8(1):96. PubMed ID: 36872366
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Melatonin-Assisted Cisplatin Suppresses Urinary Bladder cancer Cell Proliferation and Growth through Inhibiting PrP
    Yang CC; Chuang FC; Chang CL; Huang CR; Chen HH; Yip HK; Chen YT
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834767
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. α4-α5 Helices on Surface of KRAS Can Accommodate Small Compounds That Increase KRAS Signaling While Inducing CRC Cell Death.
    Abuasaker B; Garrido E; Vilaplana M; Gómez-Zepeda JD; Brun S; Garcia-Cajide M; Mauvezin C; Jaumot M; Pujol MD; Rubio-Martínez J; Agell N
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614192
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anticancer Properties of Selenium-Enriched Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), in Colon cancer In Vitro.
    Fekry T; Salem MF; Abd-Elaziz AA; Muawia S; Naguib YM; Khalil H
    Int J Med Mushrooms; 2022; 24(11):1-20. PubMed ID: 36374945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anticancer drug resistance: An update and perspective.
    Nussinov R; Tsai CJ; Jang H
    Drug Resist Updat; 2021 Dec; 59():100796. PubMed ID: 34953682
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type colorectal cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Systemic review on B-Raf
    Chavda J; Bhatt H
    Eur J Med Chem; 2020 Nov; 206():112675. PubMed ID: 32798788
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. PDCD6 cooperates with c-raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
    Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
    J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.
    Desai J; Gan H; Barrow C; Jameson M; Atkinson V; Haydon A; Millward M; Begbie S; Brown M; Markman B; Patterson W; Hill A; Horvath L; Nagrial A; Richardson G; Jackson C; Friedlander M; Parente P; Tran B; Wang L; Chen Y; Tang Z; Huang W; Wu J; Zeng D; Luo L; Solomon B
    J Clin Oncol; 2020 Jul; 38(19):2140-2150. PubMed ID: 32182156
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Potential Targets and Mechanisms of a Carbazole and Pyrazole Containing Anticancer Compound.
    Xie J; Gore JC
    Curr Cancer Drug Targets; 2020; 20(5):364-371. PubMed ID: 31951182
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular insight of regorafenib treatment for colorectal cancer.
    Arai H; Battaglin F; Wang J; Lo JH; Soni S; Zhang W; Lenz HJ
    Cancer Treat Rev; 2019 Dec; 81():101912. PubMed ID: 31715423
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR.
    Xing Y; Jing H; Zhang Y; Suo J; Qian M
    Int J Biochem Cell Biol; 2020 Jan; 118():105643. PubMed ID: 31704502
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The extended spectrum of RAS-MAPK pathway mutations in colorectal cancer.
    Costigan DC; Dong F
    Genes Chromosomes Cancer; 2020 Mar; 59(3):152-159. PubMed ID: 31589789
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Zamzam water protects cancer cells from chemotherapy-induced apoptosis via mitogen-activated protein kinase-dependent pathway.
    Siraj AK; Begum R; Melosantos R; Albalawy W; Abboud J; Siraj N; Al-Kuraya KS
    Biomed Pharmacother; 2019 Oct; 118():109376. PubMed ID: 31545262
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-κB and STAT3 regulation.
    Callejas BE; Mendoza-Rodríguez MG; Villamar-Cruz O; Reyes-Martínez S; Sánchez-Barrera CA; Rodríguez-Sosa M; Delgado-Buenrostro NL; Martínez-Saucedo D; Chirino YI; León-Cabrera SA; Pérez-Plasencia C; Vaca-Paniagua F; Arias-Romero LE; Terrazas LI
    Int J Cancer; 2019 Dec; 145(11):3126-3139. PubMed ID: 31407335
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2018 Sep; 135():239-258. PubMed ID: 30118796
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.